IMC Chicago’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49M Sell
27,000
-20,600
-43% -$2.07M ﹤0.01% 2365
2025
Q4
$4.86M Buy
47,600
+17,600
+59% +$1.57M ﹤0.01% 1754
2025
Q3
$1.87M Buy
30,000
+14,300
+91% +$778K ﹤0.01% 2276
2025
Q2
$817K Buy
+15,700
New +$701K ﹤0.01% 2598

Other funds holding GH

IMC Chicago's GH Position: Q1 2026 in Review

IMC Chicago reduced its Guardant Health (GH) stake by 15% in Q1 2026, selling an estimated $205K and leaving 11,387 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3234.

IMC Chicago first reported a position in GH in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.37M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • IMC Chicago held 11,387 shares of Guardant Health worth $1.05M as of Q1 2026.
  • IMC Chicago sold 2,041 Guardant Health shares in Q1 2026, an estimated $205K.
  • Guardant Health made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3234 holding.
  • IMC Chicago first reported a position in Guardant Health in Q4 2025 and has held it in 2 quarters since.
  • IMC Chicago's Guardant Health position peaked at $1.37M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.